Mr. Romnick Aguilar
Romnick Aguilar is the Acting Chief Nursing Officer and Infection Prevention and Control Officer of San Pedro Jose L. Amante Emergency Hospital. He holds a Master of Arts in Nursing from the University of the City of Manila and currently pursuing his Diploma in International Health at the University of the Philippines Open University. He is a Fellow of the Philippine College of Hospital Administrators and Fellow of Royal Institute of Nurses-Singapore. He is a Member of the Honor Society of Nursing Sigma Theta Tau International, International Ambassador of the Society for Healthcare Epidemiology of America and Chair of Committee on Public Relations and Advocacies of the Philippine Nurses Association.
I am a researcher and consultant in health policy and systems, looking at how health systems work; what we can learn by comparing health systems across countries; and how to bring about constructive change in health systems.
Thomas B. Cueni is Director General of IFPMA, the global association of pharmaceutical research companies, based in Geneva and is Secretary of the global Biopharmaceutical CEO Roundtable (BCR). In this capacity, Thomas Cueni was instrumental in creating the AMR Action Fund. A ground-breaking partnership, launched in 2020, that has raised nearly $1 billion to bring 2-4 new antibiotics to patients by 2030. These treatments are urgently needed to address the rapid rise of antibiotic-resistant infections – also called antimicrobial resistance, or AMR.
Thomas Cueni represents the innovative biopharmaceutical industry on the ACT Accelerator, the Access to COVID-19 Tools (ACT) Accelerator, a unique global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
Thomas Cueni is Chair of the Business at OECD Health Committee, and also serves on the Board of Directors of the City Cancer Challenge (CCan), an initiative aiming to improve cancer care in major cities in low- and middle-income countries. Cueni also serves as Industry Co-Chair of the APEC Biopharmaceutical Working Group on Ethics. Furthermore, he is Chair of the Board of the cross-sectoral AMR Industry Alliance, a group committed to tackling the threat of antimicrobial resistance, which includes more than 100 companies and associations representing Rx pharma, generics, biotech, and diagnostics.
Prior to joining IFPMA he was Secretary General of Interpharma, the association of pharmaceutical research companies in Switzerland, and for many years was a member of the Board and Chair of a key committee of the European Federation of Pharmaceutical Industries and Associations.
Prior to his appointment with Interpharma, Thomas Cueni had a career as a journalist, inter alia as London correspondent for the “Basler Zeitung” and “Der Bund”, and he served as a Swiss career diplomat with postings in Paris (OECD) and Vienna (IAEA, UNIDO). He studied at the University of Basle, the London School of Economics, and the Geneva Graduate Institute for International Studies, and has Master degrees in economics (University of Basel) and politics (London School of Economics, LSE).
Registered Nurse, educated in Care of BMT patients (UK), Master in medical-surgical nursing, Diploma in Qualitative Research , Diploma in Health management and leadership (U.Berkeley), Master in Leadership and Management of Nursing Services and Doctor in Nursing Sciences (U.Barcelona).
From 1990 she worked as a ward nurse in different medical/surgical units. Up to1996 as a ward and clinical nurse in oncology/hematology and intensive therapy. She acted as nurse support manager in the development of care standards, quality, education and learning, research and knowledge management. She is Nurse Executive in the Catalan Institute of Health Hospitals, directing the ARES program on harmonization of care plans for inpatients and outpatients, the implementation of the electronic health records and the clinical information management system, as well as the VIDA program aimed at improving nursing surveillance and prompt identification and management of avoidable complications and in-hospital mortality.
Since 2013 she acts as group leader for the Nursing Research Group at IDIBELL Institute of Biomedical Research in Barcelona.
She is the author of the ATIC Terminology, a nursing interface controlled vocabulary for the electronic health record systems. Works as associate professor at Barcelona University Nursing School, and has authored of several nursing books and scientific papers in national and international journals.
Since 2017 she is a member of the Board of Directors of the International Council of Nurses.
Adelaida Zabalegui is a Nurse since 1982 (Spain), Master and Ph.D. in Nursing from New York University (1997) as a Fellow of the Spanish Ministry of Health.
Assistant Director of Nursing at New York City Bellevue Hospital. Director of Nursing School (Universitat Internacional de Catalunya), Chief Nurse Officer and currently Vicedirector of Nursing at Hospital Clínic of Barcelona and Associate Professor at Barcelona University.
Accredited as Full Professor and Advanced Researcher in elderly care, 250 publications, director of 20 doctoral dissertations and Editor of the spanish version of the journal “Nursing”.
Member of the Boards: European Academy of Nursing Science and Nursing Now campaign (European representative).
Since June 2013, Bertrand Levrat has been the CEO of the University Hospitals of Geneva (HUG), the largest university hospital in Switzerland.
As a visionary and collaborative leader, Bertrand has driven complex and large-scale organisational changes enabling the HUG to become one of the leading university hospitals in Europe, internationally recognised for its excellence and pioneering research.
A barrister by training, Bertrand Levrat started his career on humanitarian assignments with the International Committee of the Red Cross (ICRC) in Asia, Africa, and Latin America and was ICRC’s representative at the United Nations in New York.
After returning to his home country, he became Deputy Director of the Geneva state social services before becoming CEO of the “Hospice général” which is in charge of social welfare and asylum seekers in Geneva.
In addition to his current position, he serves as President of the University Medicine Association (UNIMED) and is a board member of several foundations focusing on health and medical research as well as innovative approaches and technologies in healthcare.